In AF, adding NT‐proBNP and high‐sensitivity troponin to age and clinical history in the ABC‐stroke scheme improves discrimination and clinical decision support versus CHA2DS2‐VASc, with recent external validations in emergency department and screening contexts [132]. Here, NPPB is linked to stroke disorder.